Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)

Zobair Younossi; Maria Stepanova; Kwang-Hyub Han; Young-Suk Lim; Youn-Jae Lee; Wan-Long Chuang; Jia-Horng Kao; Rong-Nan Chien; Ting-Tsung Chang; Cheng-Yuan Peng

Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)

Zobair Younossi
, Maria Stepanova
, Kwang-Hyub Han
, Young-Suk Lim
, Youn-Jae Lee
, Wan-Long Chuang
, Jia-Horng Kao
, Rong-Nan Chien
, Ting-Tsung Chang
, Cheng-Yuan Peng

School of Traditional Chinese Medicine

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Pages (from-to)	376-376
Journal	Journal of Gastroenterology and Hepatology
Volume	31
State	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Younossi, Z., Stepanova, M., Han, K.-H., Lim, Y.-S., Lee, Y.-J., Chuang, W.-L., Kao, J.-H., Chien, R.-N., Chang, T.-T., & Peng, C.-Y. (2016). Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL). Journal of Gastroenterology and Hepatology, 31, 376-376.

@article{8a0613dc36b5494091960c89c658e98a,

title = "Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)",

author = "Zobair Younossi and Maria Stepanova and Kwang-Hyub Han and Young-Suk Lim and Youn-Jae Lee and Wan-Long Chuang and Jia-Horng Kao and Rong-Nan Chien and Ting-Tsung Chang and Cheng-Yuan Peng",

year = "2016",

language = "American English",

volume = "31",

pages = "376--376",

journal = "Journal of Gastroenterology and Hepatology",

issn = "0815-9319",

publisher = "Wiley-Blackwell Publishing Ltd",

}

Younossi, Z, Stepanova, M, Han, K-H, Lim, Y-S, Lee, Y-J, Chuang, W-L, Kao, J-H, Chien, R-N, Chang, T-T & Peng, C-Y 2016, 'Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)', Journal of Gastroenterology and Hepatology, vol. 31, pp. 376-376.

Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL). / Younossi, Zobair; Stepanova, Maria; Han, Kwang-Hyub et al.
In: Journal of Gastroenterology and Hepatology, Vol. 31, 2016, p. 376-376.

Research output: Contribution to journal › Journal Article › peer-review

TY - JOUR

T1 - Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)

AU - Younossi, Zobair

AU - Stepanova, Maria

AU - Han, Kwang-Hyub

AU - Lim, Young-Suk

AU - Lee, Youn-Jae

AU - Chuang, Wan-Long

AU - Kao, Jia-Horng

AU - Chien, Rong-Nan

AU - Chang, Ting-Tsung

AU - Peng, Cheng-Yuan

PY - 2016

Y1 - 2016

M3 - Journal Article

SN - 0815-9319

VL - 31

SP - 376

EP - 376

JO - Journal of Gastroenterology and Hepatology

JF - Journal of Gastroenterology and Hepatology

ER -